Vivo Capital, LLC
Top Portfolio Positions
44 positions ·
$1,164,469,705 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ERAS |
Erasca, Inc.
Healthcare
|
12,151,480 | $196,610,946 | 16.88% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
338,895 | $109,188,580 | 9.38% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
1,334,418 | $70,350,516 | 6.04% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
5,094,668 | $60,779,389 | 5.22% | |
| DBVT |
DBV Technologies S.A.
Healthcare
|
2,667,569 | $55,725,516 | 4.79% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
9,545,466 | $50,495,515 | 4.34% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
2,154,780 | $45,077,997 | 3.87% | |
| SABS |
SAB Biotherapeutics, Inc.
Healthcare
|
11,420,000 | $43,738,600 | 3.76% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
2,805,816 | $41,049,088 | 3.53% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
557,172 | $40,656,840 | 3.49% |
Portfolio Trend
25 quarters · across all stocks
Holdings in SLN
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $6,721,160 | 1,105,454 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,737,306 | 1,105,454 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,411,633 | 1,105,454 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,117,380 | 1,105,454 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $7,605,523 | 1,105,454 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $20,097,153 | 1,105,454 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $21,003,626 | 1,105,454 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $23,877,806 | 1,105,454 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $8,862,243 | 510,204 | Shares | Sole | 2024-02-07 | |
| No 13F history on record for this holder in this stock. | ||||||